ANDA 75963, held by Ivax Sub Teva Pharms. Tramadol Hydrochloride.
As of Nov 16, 2026, ANDA 75963 (Tramadol Hydrochloride), held by Ivax Sub Teva Pharms, was first approved by FDA on Jul 3, 2002, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 3, 2002 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tramadol Hydrochloride50MG ยท tablet;oral | Tramadol Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters